What Pharma Companies Get Wrong When Hiring Contract Sales Reps

Contract sales reps work. I want to say that upfront because the rest of this article is going to be critical of how companies use them, and I don't want the takeaway to be "contract reps are bad." They're not. The model works. What doesn't work is how most pharma companies implement it.

I keep watching the same cycle play out. A company brings on contract reps, manages them poorly, gets mediocre results, and then blames the model. "We tried contract reps. It didn't work." No. You tried contract reps and made avoidable mistakes. There's a difference.

Giving Them the Scraps

This is the one I feel strongest about.

Companies bring on contract reps and assign them the territories nobody on the permanent team wanted. The ones with weak physician density. The ones where the formulary access is bad. The ones with a competitor so entrenched that a two-year relationship-building effort might yield marginal gains.

Then the contract reps underperform relative to the permanent team. Shocking.

I watched this play out at a company that launched with eight contract reps last year. Every one of them got a territory that the regional directors described in the planning meeting as "challenging." The five permanent reps got the territories that were described as "high potential." By quarter two, the data showed permanent reps outperforming contract reps, and leadership was questioning whether the contract model added value.

Nobody questioned whether the territory assignment was the problem. I did, and it wasn't a popular observation.

If you're going to use contract reps, give them viable territories. If every territory in your deployment is equally viable, distribute them without bias between permanent and contract reps. If some territories are genuinely worse, acknowledge that in the performance expectations rather than judging the contract team against a permanent team that got a head start.

Skipping Training

The logic goes: they're experienced, they know how to sell, we're paying for speed, so let's get them in the field immediately.

The logic is wrong.

Experienced means they know how to sell. It doesn't mean they know your product. The clinical data, the competitive positioning, the formulary landscape, the approved messaging, the compliance boundaries; all of that is product-specific. An experienced rep can learn it faster than a new grad, absolutely. But faster isn't instant.

The right approach is a compressed training program. Three to five days, focused on what the rep needs to know to be credible in a physician conversation. Cut the benefits enrollment, the corporate values video, and the two-day team-building exercise that your permanent new hires sit through. Keep the clinical data review, the competitive landscape overview, the formulary and access training, the CRM walkthrough, and the compliance essentials.

Companies that do this see their contract reps become productive in two to three weeks. Companies that skip training entirely see their contract reps fumble through the first six weeks, sometimes damaging physician relationships in the process.

The 1099 Compliance Problem

This one is less about performance and more about legal risk, but it matters.

When you engage a 1099 independent contractor, there are rules about how that relationship is structured. You define the outcomes and the territory. The contractor determines how they achieve the results. You cannot require specific working hours, mandate attendance at specific meetings, dictate daily call schedules, or manage their activity the way you'd manage a W2 employee.

I see companies violate this constantly, usually not out of malice but out of habit. They're used to managing employees. They create "contractor handbooks" that read like employee handbooks. They require contract reps to submit daily call logs by 6pm. They mandate attendance at 8am Monday team calls. They require use of a company-provided laptop with monitoring software.

Every one of those practices pushes the engagement toward employee classification, regardless of what the contract says. If the IRS or a state labor board reviews the arrangement, the contract language matters less than the actual working conditions. The risk isn't theoretical. Companies have been reclassified and hit with back taxes, penalties, and benefits obligations.

Structure the engagement correctly from the start. Define clear deliverables and expectations. Give the contractor autonomy on execution. If you need that level of daily management control, hire a W2 employee or use a CSO that employs the reps as W2s under their own umbrella.

Our guide to hiring 1099 pharmaceutical sales reps covers the compliance framework in more detail.

Isolating Them from the Team

Contract reps who don't have access to the same information as the permanent team sell with one hand tied behind their back.

If your permanent reps have a regional group chat where they share competitive intelligence and the contract reps aren't in it, the contract reps are making calls with less information. If the medical affairs team hosts a weekly Q&A that the permanent team dials into but contract reps aren't invited to, the contract reps are less prepared for clinical questions. If there's a new prior authorization workaround that someone figured out and shared on the team Slack, and the contract reps aren't on the Slack, they don't have it.

This isn't about making contract reps "feel included" as some kind of morale exercise. It's about giving them the information they need to sell effectively. Information asymmetry directly affects performance.

One company I know assigned each contract rep a buddy from the permanent team, someone in a neighboring territory who could share intel, answer questions, and flag anything the contract rep might miss. It cost nothing and measurably improved the contract reps' effectiveness. Not every idea needs to be complicated.

When Contract Reps Work vs. When They Don't

Title: When Contract Reps Work vs. When They Don't

Be honest with yourself about which situation you're in before you engage anyone.

What Good Execution Looks Like

I'll keep this short because it's basically the inverse of the mistakes above.

Train them. Give them viable territories. Include them in the team's information flow. Structure the 1099 relationship correctly. And use them in situations where the model is actually appropriate.

The companies that do these things get strong results from contract reps. In some cases, the contract reps outperform parts of the permanent team, which I've seen create its own set of organizational politics, but that's a separate conversation.

The trend toward contract models in pharma sales is accelerating. Based on what I've seen in the companies I work with and broader industry conversations, the percentage of field sales roles filled by contract professionals has roughly doubled in the past five years. I don't have a single authoritative data source for that; it's a pattern I've pieced together from placement data, industry conferences, and conversations with about thirty commercial leaders over the past year. But the direction is unmistakable. Companies that learn to use the model effectively will have a flexibility advantage. Companies that keep making these mistakes will keep concluding that "contract reps don't work" while their competitors prove otherwise.